Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke
Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite, the production of which in vivo is mainly regulated by dietary choices, gut microbiota, and the hepatic enzyme flavin monooxygenase (FMO), while its elimination occurs via the kidneys. The TMAO level is positively correlated with...
Saved in:
| Main Authors: | Zhen Li, Xinyi He, Qi Fang, Xulong Yin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/14/11/1463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trimethylamine N-oxide generation process was influenced by the proportion and source of macronutrients in the diet
by: Chengcheng Wang, et al.
Published: (2024-03-01) -
Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis
by: Xiaohui Leng, et al.
Published: (2025-01-01) -
Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
by: Yuhua Zhou, et al.
Published: (2025-01-01) -
Crosstalk between Gut Microbiota Metabolites and Ischemic Stroke
by: TANG Qiang
Published: (2022-10-01) -
Research progress on the relationship between gut microbiota and ferroptosis after ischemic stroke
by: PEI Xinyu, et al.
Published: (2024-12-01)